Journal of hepatocellular carcinoma

Keyphrases

Publications

volume 11, 2024

Jiaming Shen, Xia Wang, Guangde Yang, Li Li, Juanjuan Fu, Wei Xu, Qingqiao Zhang, Xiucheng Pan
Liver Injury and Its Impact on Prognosis in Patients with HBV-Related Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors Plus Immune Checkpoint Inhibitors. Journal of hepatocellular carcinoma 11 (2024)
Ziran Wang, Lingjun Kong, Rui Zhang, Xiaobo Yang, Zhe Cao, Teng-Da Xu, Han Zhang, Yaling Dou
Serum Aldo-Keto Reductase Family 1 Member B10 (AKR1B10) as a Potential Biomarker for Diagnosis of Hepatocellular Carcinoma. Journal of hepatocellular carcinoma 11 (2024)
Tianhao Cong, Chao Yang, Qi Cao, Jinrui Ren, Yin-Gen Luo, Pei Yuan, Bo Zheng, Yu Liu, Hongcai Yang, Wendi Kang, Aixin Ou, Xiao Li
The Role of GNMT and MMP12 Expression in Determining TACE Efficacy: Validation at Transcription and Protein Levels. Journal of hepatocellular carcinoma 11 (2024)
Fernand Bteich, Kush Desai, Chenxin Zhang, Anahat Kaur, Rachel A Levy, Lydia Bioh, Aaron Wang, Sharmin Sultana, Andreas Kaubisch, Milan Kinkhabwala, Sarah Bellemare, Shabnam Fidvi, Devaraju Kanmaniraja, Robert Berkenblit, Jee-Young Moon, Adebola Adedimeji, Clara Y Tow, Yvonne M Saenger
Immunotherapy Efficacy in Advanced Hepatocellular Carcinoma in a Diverse and Underserved Population in the United States. Journal of hepatocellular carcinoma 11 (2024)
Ruyu Han, Leijuan Gan, Mengran Lang, Guangtao Li, Lu Chen, Xindi Tian, Kangwei Zhu, Liyu Sun, Tianqiang Song
A Retrospective Study on Predicting Recurrence of Intermediate-Stage Hepatocellular Carcinoma After Radical Therapy. Journal of hepatocellular carcinoma 11 (2024)
Hongyi Yang, Linbin Lu, Wangting Guo, Baocuo Gong, Xuewen Wang, Yaying Chen, Xiong Chen
A Longitudinal Study of AFP Trajectories and Clinical Outcomes in Intermediate-Stage Hepatocellular Carcinoma After Hepatectomy. Journal of hepatocellular carcinoma 11 (2024)
Yuhua Mai, Liheng Meng, Ganlu Deng, Yingfen Qin
The Role of Type 2 Diabetes Mellitus-Related Risk Factors and Drugs in Hepatocellular Carcinoma. Journal of hepatocellular carcinoma 11 (2024)
Tongguo Miao, Xianzhe Lou, Shiming Dong, Xiaoxiao Zhang, Weiwei Guan, Ying Zhang, Lu Li, Xiwei Yuan, Dong Ma, Yuemin Nan
Monocyte-to-High-Density Lipoprotein-Cholesterol Ratio Predicts Prognosis of Hepatocellular Carcinoma in Patients with Metabolic-Associated Fatty Liver Disease. Journal of hepatocellular carcinoma 11 (2024)
Jia Yan, Ke Xin Li, Lei Yu, Heng Ye Yuan, Zhi Min Zhao, Jing Lin, Chang Shan Wang
PRMT1 Integrates Immune Microenvironment and Fatty Acid Metabolism Response in Progression of Hepatocellular Carcinoma. Journal of hepatocellular carcinoma 11 (2024)
Tianhao Cong, Chao Yang, Qi Cao, Jinrui Ren, Yin-Gen Luo, Pei Yuan, Bo Zheng, Yu Liu, Hongcai Yang, Wendi Kang, Aixin Ou, Xiao Li
The Role of GNMT and MMP12 Expression in Determining TACE Efficacy: Validation at Transcription and Protein Levels. Journal of hepatocellular carcinoma 11 (2024)
Fernand Bteich, Kush Desai, Chenxin Zhang, Anahat Kaur, Rachel A Levy, Lydia Bioh, Aaron Wang, Sharmin Sultana, Andreas Kaubisch, Milan Kinkhabwala, Sarah Bellemare, Shabnam Fidvi, Devaraju Kanmaniraja, Robert Berkenblit, Jee-Young Moon, Adebola Adedimeji, Clara Y Tow, Yvonne M Saenger
Immunotherapy Efficacy in Advanced Hepatocellular Carcinoma in a Diverse and Underserved Population in the United States. Journal of hepatocellular carcinoma 11 (2024)
Hao Yang, Guanglin Lei, Zhuoya Deng, Fang Sun, Yuying Tian, Jinxia Cheng, Hongyu Yu, Cong Li, Changqing Bai, Shaogeng Zhang, Guangwen An, Penghui Yang
An Engineered Influenza a Virus Expressing the Co-Stimulator OX40L as an Oncolytic Agent Against Hepatocellular Carcinoma. Journal of hepatocellular carcinoma 11 (2024)
Xun Qiu, Libin Dong, Kai Wang, Xinyang Zhong, Hanzhi Xu, Shengjun Xu, Haijun Guo, Xuyong Wei, Wei Chen, Xiao Xu
Development and Validation of a Novel Nomogram Integrated with Hypoxic and Lactate Metabolic Characteristics for Prognosis Prediction in Hepatocellular Carcinoma. Journal of hepatocellular carcinoma 11 (2024)
Hongyi Yang, Linbin Lu, Wangting Guo, Baocuo Gong, Xuewen Wang, Yaying Chen, Xiong Chen
A Longitudinal Study of AFP Trajectories and Clinical Outcomes in Intermediate-Stage Hepatocellular Carcinoma After Hepatectomy. Journal of hepatocellular carcinoma 11 (2024)
Xun Qiu, Libin Dong, Kai Wang, Xinyang Zhong, Hanzhi Xu, Shengjun Xu, Haijun Guo, Xuyong Wei, Wei Chen, Xiao Xu
Development and Validation of a Novel Nomogram Integrated with Hypoxic and Lactate Metabolic Characteristics for Prognosis Prediction in Hepatocellular Carcinoma. Journal of hepatocellular carcinoma 11 (2024)
Han Wang, Jun-Jie Chen, Shu-Yi Yin, Xia Sheng, Hong-Xia Wang, Wan Yee Lau, Hui Dong, Wen-Ming Cong
A Grading System of Microvascular Invasion for Patients with Hepatocellular Carcinoma Undergoing Liver Resection with Curative Intent: A Multicenter Study. Journal of hepatocellular carcinoma 11 (2024)
Changzhi Chen, Jieyun Cai, Ling Li
Effect of Different Liver Resection Modalities on the Prognosis of Patients with Hepatocellular Carcinoma on the Left Lateral Lobe [Letter]. Journal of hepatocellular carcinoma 11 (2024)
Xiaoju Huang, Mengmeng Wang, Dan Zhang, Chen Zhang, Pian Liu
Advances in Targeted Drug Resistance Associated with Dysregulation of Lipid Metabolism in Hepatocellular Carcinoma. Journal of hepatocellular carcinoma 11 (2024)
Han Wang, Jun-Jie Chen, Shu-Yi Yin, Xia Sheng, Hong-Xia Wang, Wan Yee Lau, Hui Dong, Wen-Ming Cong
A Grading System of Microvascular Invasion for Patients with Hepatocellular Carcinoma Undergoing Liver Resection with Curative Intent: A Multicenter Study. Journal of hepatocellular carcinoma 11 (2024)
Wenying Qiao, Zibo Fan, Qi Wang, Ronghua Jin, Caixia Hu
Development and Validation of a Nomogram to Predict the Recurrence of HCC Patients Undergoing CECT After Ablation. Journal of hepatocellular carcinoma 11 (2024)
Hao Yang, Guanglin Lei, Zhuoya Deng, Fang Sun, Yuying Tian, Jinxia Cheng, Hongyu Yu, Cong Li, Changqing Bai, Shaogeng Zhang, Guangwen An, Penghui Yang
An Engineered Influenza a Virus Expressing the Co-Stimulator OX40L as an Oncolytic Agent Against Hepatocellular Carcinoma. Journal of hepatocellular carcinoma 11 (2024)
Ruyu Han, Leijuan Gan, Mengran Lang, Guangtao Li, Lu Chen, Xindi Tian, Kangwei Zhu, Liyu Sun, Tianqiang Song
A Retrospective Study on Predicting Recurrence of Intermediate-Stage Hepatocellular Carcinoma After Radical Therapy. Journal of hepatocellular carcinoma 11 (2024)
Qing-Qing Luo, Qiao-Nan Li, Dan Cai, Song Jiang, Shao-Song Liu, Mao-Sheng Liu, Cong Lv, Jin-Ke Wang, Kun-He Zhang, Ting Wang
The Index sAGP is Valuable for Distinguishing Atypical Hepatocellular Carcinoma from Atypical Benign Focal Hepatic Lesions. Journal of hepatocellular carcinoma 11 (2024)
Julien Ghelfi, Zuzana Macek Jilkova, Christian Sengel, Bleuenn Brusset, Yann Teyssier, Charlotte Costentin, Marion Mercey-Ressejac, Lucile Dumolard, Marc Manceau, Eliott Mathieu, Ivan Bricault, Thomas Decaens
PD1 and TIM3 Expression is Associated with Very Early Hepatocellular Carcinoma Recurrence After Percutaneous Thermal Ablation. Journal of hepatocellular carcinoma 11 (2024)
Julien Ghelfi, Zuzana Macek Jilkova, Christian Sengel, Bleuenn Brusset, Yann Teyssier, Charlotte Costentin, Marion Mercey-Ressejac, Lucile Dumolard, Marc Manceau, Eliott Mathieu, Ivan Bricault, Thomas Decaens
PD1 and TIM3 Expression is Associated with Very Early Hepatocellular Carcinoma Recurrence After Percutaneous Thermal Ablation. Journal of hepatocellular carcinoma 11 (2024)
Wenying Qiao, Jiashuo Li, Qi Wang, Ronghua Jin, Honghai Zhang
Development and Validation of a Prognostic Nomogram for Patients with AFP and DCP Double-Negative Hepatocellular Carcinoma After Local Ablation. Journal of hepatocellular carcinoma 11 (2024)
Jia Yan, Ke Xin Li, Lei Yu, Heng Ye Yuan, Zhi Min Zhao, Jing Lin, Chang Shan Wang
PRMT1 Integrates Immune Microenvironment and Fatty Acid Metabolism Response in Progression of Hepatocellular Carcinoma. Journal of hepatocellular carcinoma 11 (2024)
Jin-Shu Pang, Xiu-Mei Bai, Wei-Jun Wan, Tong Kang, Rong Wen, Li-Peng Li, Hai-Hui Yin, Chun-Miao Lu, Dong-Yue Wen, Yun He, Hong Yang
RAD21: A Key Transcriptional Regulator in the Development of Residual Liver Cancer. Journal of hepatocellular carcinoma 11 (2024)
Wenying Qiao, Jiashuo Li, Qi Wang, Ronghua Jin, Honghai Zhang
Development and Validation of a Prognostic Nomogram for Patients with AFP and DCP Double-Negative Hepatocellular Carcinoma After Local Ablation. Journal of hepatocellular carcinoma 11 (2024)
Zhan Shi, Sihui Zhu, Yuncheng Jin, Liang Qi, Mingzhen Zhou, Ziyan Zhou, Juan Zhang, Baorui Liu, Jie Shen
Lymphocyte-to-C Reactive Protein Ratio is an Independent Predictor of Survival Benefits for Hepatocellular Carcinoma Patients Receiving Radiotherapy. Journal of hepatocellular carcinoma 11 (2024)
Chunhui Zhang, Yuqing Tao, Rui Yang, Yueqi Wang, Yanyan Yu, Yang Zhou
Prediction of Non-Transplantable Recurrence After Liver Resection for Solitary Hepatocellular Carcinoma. Journal of hepatocellular carcinoma 11 (2024)
Chunhui Zhang, Yuqing Tao, Rui Yang, Yueqi Wang, Yanyan Yu, Yang Zhou
Prediction of Non-Transplantable Recurrence After Liver Resection for Solitary Hepatocellular Carcinoma. Journal of hepatocellular carcinoma 11 (2024)
Hongcai Yang, Tianhao Cong, Yin-Gen Luo, Chao Yang, Jinrui Ren, Xiao Li
Prognostic Effect of Sarcopenia in Hepatocellular Carcinoma Patients Targeted with Interventional Therapy Combined with Immunotherapy and Targeted Therapy. Journal of hepatocellular carcinoma 11 (2024)
Qing-Qing Luo, Qiao-Nan Li, Dan Cai, Song Jiang, Shao-Song Liu, Mao-Sheng Liu, Cong Lv, Jin-Ke Wang, Kun-He Zhang, Ting Wang
The Index sAGP is Valuable for Distinguishing Atypical Hepatocellular Carcinoma from Atypical Benign Focal Hepatic Lesions. Journal of hepatocellular carcinoma 11 (2024)
Jiaming Shen, Xia Wang, Guangde Yang, Li Li, Juanjuan Fu, Wei Xu, Qingqiao Zhang, Xiucheng Pan
Liver Injury and Its Impact on Prognosis in Patients with HBV-Related Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors Plus Immune Checkpoint Inhibitors. Journal of hepatocellular carcinoma 11 (2024)
Hongcai Yang, Tianhao Cong, Yin-Gen Luo, Chao Yang, Jinrui Ren, Xiao Li
Prognostic Effect of Sarcopenia in Hepatocellular Carcinoma Patients Targeted with Interventional Therapy Combined with Immunotherapy and Targeted Therapy. Journal of hepatocellular carcinoma 11 (2024)
Yuhua Mai, Liheng Meng, Ganlu Deng, Yingfen Qin
The Role of Type 2 Diabetes Mellitus-Related Risk Factors and Drugs in Hepatocellular Carcinoma. Journal of hepatocellular carcinoma 11 (2024)
Changzhi Chen, Jieyun Cai, Ling Li
Effect of Different Liver Resection Modalities on the Prognosis of Patients with Hepatocellular Carcinoma on the Left Lateral Lobe [Letter]. Journal of hepatocellular carcinoma 11 (2024)
Tongguo Miao, Xianzhe Lou, Shiming Dong, Xiaoxiao Zhang, Weiwei Guan, Ying Zhang, Lu Li, Xiwei Yuan, Dong Ma, Yuemin Nan
Monocyte-to-High-Density Lipoprotein-Cholesterol Ratio Predicts Prognosis of Hepatocellular Carcinoma in Patients with Metabolic-Associated Fatty Liver Disease. Journal of hepatocellular carcinoma 11 (2024)
Wenying Qiao, Zibo Fan, Qi Wang, Ronghua Jin, Caixia Hu
Development and Validation of a Nomogram to Predict the Recurrence of HCC Patients Undergoing CECT After Ablation. Journal of hepatocellular carcinoma 11 (2024)
Xiaoju Huang, Mengmeng Wang, Dan Zhang, Chen Zhang, Pian Liu
Advances in Targeted Drug Resistance Associated with Dysregulation of Lipid Metabolism in Hepatocellular Carcinoma. Journal of hepatocellular carcinoma 11 (2024)
Zhan Shi, Sihui Zhu, Yuncheng Jin, Liang Qi, Mingzhen Zhou, Ziyan Zhou, Juan Zhang, Baorui Liu, Jie Shen
Lymphocyte-to-C Reactive Protein Ratio is an Independent Predictor of Survival Benefits for Hepatocellular Carcinoma Patients Receiving Radiotherapy. Journal of hepatocellular carcinoma 11 (2024)
Robert Mahn, Oscar André Glüer, Farsaneh Sadeghlar, Christian Möhring, Taotao Zhou, Thomas Anhalt, Malte Benedikt Monin, Alexander Kania, Tim R Glowka, Georg Feldmann, Peter Brossart, Joerg C Kalff, Ingo G H Schmidt-Wolf, Christian P Strassburg, Maria A Gonzalez-Carmona
First-Line Treatment for Advanced Hepatocellular Carcinoma: A Three-Armed Real-World Comparison. Journal of hepatocellular carcinoma 11 (2024)
Robert Mahn, Oscar André Glüer, Farsaneh Sadeghlar, Christian Möhring, Taotao Zhou, Thomas Anhalt, Malte Benedikt Monin, Alexander Kania, Tim R Glowka, Georg Feldmann, Peter Brossart, Joerg C Kalff, Ingo G H Schmidt-Wolf, Christian P Strassburg, Maria A Gonzalez-Carmona
First-Line Treatment for Advanced Hepatocellular Carcinoma: A Three-Armed Real-World Comparison. Journal of hepatocellular carcinoma 11 (2024)
Jianwei Liu, Minmin Sun, Kunpeng Fang, Jie Wang, Bowen Ma, Li Song, Ting Liu, Ming Tang, Kui Wang, Yong Xia
Effect of Different Liver Resection Modalities on the Prognosis of Patients with Hepatocellular Carcinoma on the Left Lateral Lobe [Response to Letter]. Journal of hepatocellular carcinoma 11 (2024)
Kangze Wu, Feizhuan Lin
Lipid Metabolism as a Potential Target of Liver Cancer. Journal of hepatocellular carcinoma 11 (2024)
Changzhi Chen, Jieyun Cai, Ling Li
Effect of Different Liver Resection Modalities on the Prognosis of Patients with Hepatocellular Carcinoma on the Left Lateral Lobe [Letter]. Journal of hepatocellular carcinoma 11 (2024)
Ziran Wang, Lingjun Kong, Rui Zhang, Xiaobo Yang, Zhe Cao, Teng-Da Xu, Han Zhang, Yaling Dou
Serum Aldo-Keto Reductase Family 1 Member B10 (AKR1B10) as a Potential Biomarker for Diagnosis of Hepatocellular Carcinoma. Journal of hepatocellular carcinoma 11 (2024)
Liwei Deng, Yanyuan Sun, Haiqing Wang, Changli Liao, Deshan Li, Guohui Xu, Xuegang Yang
Efficacy and Safety of Transarterial Chemoembolization Plus Donafenib with or without Immune Checkpoint Inhibitors as the First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Analysis. Journal of hepatocellular carcinoma 11 (2024)
Liwei Deng, Yanyuan Sun, Haiqing Wang, Changli Liao, Deshan Li, Guohui Xu, Xuegang Yang
Efficacy and Safety of Transarterial Chemoembolization Plus Donafenib with or without Immune Checkpoint Inhibitors as the First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Analysis. Journal of hepatocellular carcinoma 11 (2024)